Cosmetics Reform Bill Relaunches In Senate, Sending Stakeholders To Familiar Corners
This article was originally published in The Rose Sheet
Executive Summary
The Personal Care Products Safety Act introduced in the Senate May 11, and the Cosmetic Modernization Amendments Act that launched in the House earlier this year, closely mirror versions that divided big and small business in the last Congress. So while the US political environment may be dramatically changed, the legislative situation for stakeholders seeking updated cosmetics regulations, at the moment, is not.
You may also be interested in...
‘California’s A Problem,’ But Prop 65 Preemption For Cosmetics Could Be Out Of Reach
California is the poster child for regulation in excess of federal requirements, but the biggest challenges it poses to cosmetics companies will be difficult – if not impossible – to resolve via “national uniformity” provisions in legislation before Congress.
Trump's Budget Surprise: FDA Gets 13% Increase
President Trump's FY 2019 budget request includes $473m in new non-user fee revenue for the US agency, a reversal of the previous year's request.
ICMAD Beefs Up Lobbying To Deter 'Wrong Decision' In Congress
Pam Busiek, head of the Independent Cosmetic Manufacturers and Distributors, discusses the trade group's ongoing work in Washington where multiple, differently sized bills for updating cosmetics regulations are under consideration. Notably, ICMAD's roster of advocates now includes former FDA Cosmetics Director John Bailey.